A preparative, high-speed, counter-current chromatographic (HSCCC) method for the isolation and purification of bufadienolides from Chansu was successfully developed by using stepwise elution with a two-phase solvent system composed of n-hexane: chloroform: methanol: water (4:1:2.5:5 and 4:1:4:5, v/v). A total of 7.5 mg of cinobufotalin (1), 8.0 mg of bufalin (2), 14.0 mg of cinobufagin (3) and 9.5 mg of resibufogenin (4) were obtained in a one-step separation from 80 mg of the crude extract with purities of 93.2%, 98.7%, 99.2%, and 99.4%, respectively. The chemical structures were determined from 1 H NMR and 13 C NMR spectroscopic data.
Chansu, a traditional Chinese medicine (TCM), is obtained from the skin secretions of local toads, such as Bufo gararizans Cantor and B. melanostictus Schneider [1, 2] . It is widely used in clinics to treat various cancers and heart failure. The cardioactive steroids bufalin, cinobufagin and resibufogenin are the major bioactive constituents of Chansu. They were considered to be the most potent cytotoxic natural compounds with IC 50 values of 1-10 nM against human leukemia cells [3] [4] [5] [6] . These bufadienolides were also used as the standard compounds for quantification of bufadienolide concentrations in plasma for drug monitoring in clinical studies [7] [8] [9] [10] and for the quality control of Chansu and its related preparations [1, 11] . However, because these bufadienolides have similar structures, the various chromatographic methods used to separate them, such as HPLC and column chromatography (CC) [11] [12] [13] , result in a great loss of target compounds, and use large amounts of reagent. Thus, it is necessary to develop a simple and rapid method to obtain the major bufadienolides of Chansu with high purities. High-speed counter-current chromatography (HSCCC) has been successfully applied to prepare various types of natural products [14] [15] [16] [17] [18] . In the present paper, a simple and efficient HSCCC approach was developed to isolate and purify four major compounds from the crude extract of Chansu [cinobufotalin (1), bufalin (2), cinobufagin (3) and resibufogenin (4) with purities of 93.2%, 98.7%, 99.2% and 99.4%, respectively] ( Figure 1 ). Their structures were identified from 1 H and 13 C NMR spectral data. 
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Selection of two-phase-solvent system and other conditions for HSCCC:
A successful HSCCC separation mainly depends on the selection of a suitable two-phase solvent system. This is chosen according to the partition coefficient values (K) and the separation factor (α) of each target component. Additionally, due to the complex components of herbal medicines, it is very difficult to separate and purify the target compounds with high purities by using only one part of the two solvent-phase system in the process of HSCCC separation. In our present work, considering the low polarity of bufadienolides, a two-phase solvent system composed of n-hexane-chloroform-methanol-water in different volume ratios was selected to measure the K values of the target compounds. With the two-phase solvent system in the ratio of 4:1:2.5:5, the K values of compounds 1 and 2 were suitable, and the separation factor (α) value was 1.82. However, compounds 3 and 4 had fairly large K values. However, when the volume ratio was changed to 4:1:4:5, appropriate K and α values for 3 and 4 were observed. Considering these aspects, a two-phase solvent system, with volume rations of 4:1:2.5:5 and 4:1:4:5, was applied in a single run by stepwise elution. In addition, the influences of the flow rate of the mobile phase and the revolution speed were investigated. Our results indicated that a fast flow speed could result in poor separation due to the crowding of the chromatographic peaks. However, a fast revolution speed resulted in satisfactory separation. As a result, the flow rate was selected as 1.5 mL min -1 and the revolution speed was set at 900 rpm.
Under the optimized HSCCC conditions, good separation was achieved. The retention of the stationary phase was 62%. A total of 7.5 mg of cinobufotalin (1), 8.0 mg of bufalin (2), 14.0 mg of cinobufagin (3) and 9.5 mg of resibufogenin (4) was obtained in a one-step separation from 80 mg of the crude extract with purities of 93.2%, 98.7%, 99.2% and 99.4%, respectively.
The separated peaks from the crude extract of Chansu were identified as cinobufotalin [11] , bufalin [19] , cinobufagin [19] and resibufogenin [19] , according to their 1 H and 13 C NMR spectroscopic data, which agreed with those reported in the literature.
Conclusions:
Our results show that HSCCC, with stepwise elution, is a very powerful technology for the preparative isolation of natural products, especially for the major bioactive or toxic components of traditional Chinese medicines. The bufadienolides (1-4) obtained with high purities from Chansu by HSCCC could be used as reference samples for investigating their pharmacological mechanisms, metabolism in vivo and for the quality control of drug preparations containing Chansu.
Experimental
Apparatus:
The HSCCC instrument employed in the present study was the TBE-300B high-speed countercurrent chromatograph (Shanghai Tauto Biotech Co., Shanghai, China), with 3 preparative multilayer coil separation columns connected in series (diameter of tube =2.6 mm, total volume = 300 mL) and a 20 mL sample loop. The revolution radius or the distance between the central axis of the centrifuge (R) and the holder axis was 5 cm, and the β values of the multilayer coil varied from 0.5 at the internal terminal to 0.8 at the external one (β = r/R, where r is the distance from the coil to the holder shaft). The revolution speed of the apparatus can be regulated with a speed controller in the range between 0 and 1000 rpm. An HX 1050 constanttemperature circulation implement (Beijing Byoikang Lab Instrument Company, Beijing, China) was used to control temperature in the process of isolation. An AKTA prime system (Amersham Pharmacia Biotechnique Group, Sweden) was used to pump the two-phase solvent system and the UV absorbance measurement was performed by Lab Alliance Model 201. The HPLC equipment used was the Ultimate 3000 HPLC system with pump, autosampler, column compartment and photodiode array detector. The identification of compounds 1-4 was performed on a Bruker DRX-500 NMR spectrometer. 1 H and 13 C NMR spectra (at 500 and 125MHz, respectively) were measured at room temperature (22 0 C /295.1 K).
Reagents and materials:
The organic solvents for the preparation of the crude extract and HSCCC separation were of analytical grade (Beijing Chemical Factory, China). Acetonitrile and methanol for HPLC were chromatographic grade (Merck, Darmstadt, Germany), and the water used was distilled. The crude materials of Chansu were collected from Qingdao, Shandong Province of China, and identified by Prof. JM Jia; a voucher specimen has been deposited at the School of Pharmacy, Dalian Medical University.
Preparation of crude sample:
Dried materials (50 g) were extracted with 1.5 L of chloroform, 3 times, under refluxing conditions. The pooled extracts were collected and concentrated under reduced pressure. Finally, about 18.0 g of crude extract was obtained.
Selection of two-phase solvent systems:
The two-phase solvent systems were selected according to the partition coefficients (K) of the target components in the crude sample of Chansu. The solvents were mixed thoroughly and left for 15 min. After equilibration was established, the upper and lower phases were analyzed by HPLC, respectively. The peak area of a target compound in the upper phase was measured as A 1 , and its peak area in HSCCC separation of bufadienolides Natural Product Communications Vol. 5 (7) 2010 1033 the lower phase was recorded as A 2 . The K value was calculated according to the following equation:
Preparation of two-phase solvent system and sample solution:
In the present work, n-hexane: chloroform: methanol: water in the ratios of 4:1:2.5:5 (v/v) and 4:1:4:5 (v/v) were used as the two-phase solvent system for HSCCC separation. These were prepared by adding the solvents to a separation funnel, equilibrating at room temperature overnight, and then separation of the upper and lower phases, which were then degassed in an ultrasonic bath for 30 min before use. The sample solution for HSCCC separation was prepared by dissolving 80 mg of the crude extract in 12 mL of the two-phase solvent system, including 6 mL of the upper phase and 6 mL of the lower phase.
HSCCC separation procedure: HSCCC separation was performed as follows: first, the multilayer-coil column was entirely filled with the upper phase. Then the lower phase was pumped from the head end of the column at a flow rate of 1.5 mL min -1 , while the apparatus was rotated at 900 rpm. After dynamic equilibrium was established, as indicated by a clear mobile phase eluting at the tail outlet, the sample solution was injected through the sample port. The effluent from the tail end of the column was continuously monitored with a UV detector at 296 nm. Each peak fraction was collected according to the chromatogram and then evaporated under reduced pressure. The residues were dissolved in methanol for purity analysis by HPLC. Retention values were computed according to the volume of the stationary phase collected from the column after HSCCC separation was completed.
HPLC analysis and identification of HSCCC peak fractions: All the HSCCC peak fractions were analyzed by HPLC. The analysis was accomplished with an Agilent ODS C 18 column (250 mm×4.6 mm, ID 5μm). The mobile phase was composed of solvent A (0.3% aqueous acetic acid, v/v) and B (acetonitrile) in a linear gradient. The gradient program was as follows: initial 0-5 min, using a constant elution A-B (70:30, v/v), then 5-25 min, linear change from A-B (70:30, v/v) to A-B (50:50, v/v); next 25-35 min, using a constant elution A-B (50:50, v/v), next 35-40 min, linear change to A-B (10:90, v/v). Detection wavelength and flow rate were set at 296 nm and 0.8 mL min -1 , respectively; the column temperature was controlled at 30°C. HPLC chromatograms were recorded by a CHORMELEON chromatography management system.
